BBT Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

BBT Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,143	Closed	-$234K	–	146
2015 Q3	$234K	Sell	4,143 -9,382	-69%	-$608K	0.02%	154
2015 Q2	$799K	Sell	13,525 -2,670	-16%	-$165K	0.07%	131
2015 Q1	$1.01M	Buy	+16,195	New	+$942K	0.1%	126
2014 Q2	–	Sell	-50,000	Closed	-$2.64M	–	272
2014 Q1	$2.64M	Sell	50,000 -18,523	-27%	-$856K	0.12%	192
2013 Q4	$2.75M	Buy	+68,523	New	+$2.7M	0.13%	185

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BBT Capital Management's TEVA Position: Q4 2015 in Review

BBT Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 4,143 shares — an estimated $234K sold.

BBT Capital Management first reported a position in TEVA in Q4 2013 and held it in 5 quarters. The position peaked at $2.75M in Q4 2013. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

BBT Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
BBT Capital Management sold 4,143 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $234K.
BBT Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 5 quarters.
BBT Capital Management's Teva Pharmaceutical Industries Limited position peaked at $2.75M in Q4 2013.
877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on BBT Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.